𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia : Results of an international multicenter randomized trial

✍ Scribed by Branimir Jaksic; Maura Brugiatelli; Ivo Krc; Hajna Losonczi; Jerzy Holowiecki; Ana Planinc-Peraica; Rajko Kusec; Fortunato Morabito; Pasquale Iacopino; Dieter Lutz


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
115 KB
Volume
79
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


vanced and/or progressive disease was defined by high Total Tumor Mass (TTM) score (ú9), and/or short doubling time (DT) (õ12 months), and/or bone marrow for the International Society for Chemo-Immunotherapy, Vienna failure. The response to therapy was defined by reduction of the initial TTM score.

The end points of the trial were response rate, survival, and toxicity.